Jill Koshiol, Ph.D., Dr. Koshiol earned her Ph.D. in epidemiology from the University of North Carolina at Chapel Hill School of Public Health in 2005. Subsequently, she joined the Genetic Epidemiology Branch in DCEG as a Cancer Prevention Fellow and focused on the role of HPV in cancer outside of the cervix and on infection- and immune-related conditions in lung and hematopoietic cancers. After joining IIB as a Research Fellow in 2008, Dr. Koshiol received an Earl Stadtman tenure-track position in 2010. In addition to her continued interest in investigating the epidemiology of infectious agents and cancer, Dr. Koshiol will increasingly focus on the role of immune stimulation and inflammation in carcinogenesis.
Anil K. Chaturvedi, D.V.M., Ph.D., joined IIB as a post-doctoral fellow in 2005. He received his DVM in 1999 from Andhra Pradesh Agricultural University in India and his M.P.H. and Ph.D. in epidemiology from Tulane University. Dr. Chaturvedi focuses his research on elucidating the role of infections, inflammation, and immunosuppression in cancer etiology, with a particular concentration on cancers of the head and neck as well as lung. His work also explores the role of immune suppression and immune activation in cancer etiology among persons with HIV/AIDS.
Aimée R. Kreimer, Ph.D. received a Ph.D. in Infectious Disease Epidemiology from the Johns Hopkins Bloomberg School of Public Health in 2003. She conducted post-doctoral research at both the International Agency for Research on Cancer in Lyon, France, working on the largest case-control study to date on HPV and oral cancer, as well as the National Cancer Institute, working on multiple large-scale studies of HPV and cancers of the head and neck, esophagus, and cervix.
As a tenure-track investigator, Dr. Kreimer explores the natural history of oral HPV infections, the role of HPV in head and neck cancers and other extra-cervical sites, and evaluates the potential impact of HPV vaccination on extra-cervical infections. In addition, she is expanding her research to the study of the long-term impact of HPV vaccination. As part of this research, Dr. Kreimer has taken a lead role in IIB's long-term follow-up of the Costa Rica HPV Vaccine Trial (CVT).
Mahboobeh Safaeian, Ph.D. received a Ph.D. in Infectious Disease Epidemiology from the Johns Hopkins Bloomberg School of Public Health in 2006. Subsequently, she joined the Hormonal and Reproductive Epidemiology Branch in DCEG as a Sally Rosen Kaplan Fellow, where she focused her research on viral and host co-factors for cervical carcinogenesis. In 2008, Dr. Safaeian joined the Infections and Immunoepidemiology Branch as a tenure-track investigator. In addition to studying the viral and host co-factors associated with HPV infection and cervical carcinogenesis, she has expanded her research to the study of the immunological responses to HPV natural infection and HPV vaccination.